Telix Pharma slides 10% on SEC probe into cancer treatment
Telix Pharma slides 10% on SEC probe into cancer treatment
Source link
Similar Posts
XAO Just Dropped Like A Stone
Source link
2 Gold Stocks That Won Big in 2025 Look Set to Dominate Next Year, Too
The TSX’s Basic Materials sector overwhelmingly dominated the investment landscape for most of 2025. Gold stocks are the primary drivers of the sector’s bull run. Top performers like Skeena Resources (TSX:SKE) and DPM Metals (TSX:DPM) are likely to deliver superior returns in 2026 due to an extended gold rush. Skeena Resources and DPM Metals have…
Turning $250 Monthly Into $180 Annual Dividend Income for Canadians
In July, the Financial Post highlighted that Canada’s household savings rate had soared to 6.9% in the first quarter, a figure not seen since 1996, excluding the pandemic anomaly. This savings rate reflects the portion of disposable income Canadians manage to set aside. Statistics Canada reported that the median household income after taxes in 2022…
JWL: All Izz Wheel
Source: Exchange Release of Jupiter Wagons Ltd Source link
Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
Dick’s Sporting Goods NYSE: DKS can compete with the likes of Walmart NYSE: WMT and Target NYSE: TGT and continue to gain market share because of its quality. Not all of the sporting goods products in Walmart and Target are poor quality, but many are; sporting enthusiasts who know the difference and like choice choose…
AmpliTech Group (NASDAQ:AMPG) Issues Quarterly Earnings Results
AmpliTech Group (NASDAQ:AMPG – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.02). AmpliTech Group had a negative net margin of 77.94% and a negative return on equity of 29.49%. Source link
